Seattle Children's Hospital

Date of Award

11.07.19

Program

Type 1 Diabetes: Prevent and Delay T1D

Amount

$4,188,786

Term of Grant

36

Project Title

Development of antigen-specific eTreg therapy in T1D - Stage 3 Studies

Funds will support studies to develop an engineered targeted Treg cell therapy to treat type 1 diabetes.